A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

A nasal vaccine for COVID-19 – based on technology developed at ... Participants will be randomly assigned to one of four groups: low-dose intranasal, high-dose intranasal, low-dose inhaled and ...

Scientists have now deciphered the structure of the avian influenza ... Nasal Spray Flu Vaccine Candidate Shows Promise When Administered Alongside High Dose Annual Shot Aug. 15, 2024 — A unique ...

H5 Influenza Vaccines: What Needs to Be Done to Reduce the Risk of a Pandemic Sep. 4, 2024 — As the global threat of H5N1 influenza looms with outbreaks across species and continents including ...

Protective efficacy was 70% in the low-dose group and 80% in the high-dose group, answering concerns that the effectiveness of the vaccine may wane over time, as has been seen with some older ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

Currently, the newly-emerged highly pathogenic avian influenza A (H7N9) virus poses a dual challenge for public health and poultry industry. Numerous H7N9 vaccine candidates have been generated using ...

netvision.net.il Objective: To assess the effect of rituximab on the efficacy and safety of influenza virus vaccine in patients with rheumatoid arthritis (RA). Methods: The study group comprised ...

Background Escitalopram is licensed for use at doses up to 20 mg but is used clinically at higher doses. There is limited published data at higher doses and none in the treatment of Major ...

The development and use of aquatic vaccines are the safest and most effective ways to prevent aquatic animal diseases and preserve the health and sustainability of aquaculture. To give references for ...